Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity
2005 ◽
Vol 48
(4)
◽
pp. 1107-1131
◽
2007 ◽
Vol 50
(4)
◽
pp. 603-606
◽
2001 ◽
Vol 44
(17)
◽
pp. 2719-2734
◽
2016 ◽
Vol 59
(17)
◽
pp. 8103-8124
◽
2016 ◽
Vol 13
(02)
◽